This inventor holds 9 USPTO granted patents, plus 3 CIPO patents and 5 EPO patents. Top assignee: Zumutor Biologics Inc.. Active years: 2018-2025.
Location History:
- Karnataka Bangalore, IN (2022)
- Bengaluru, IN (2018 - 2023)
Company Filing History:
Years Active: 2018-2025
Title: Maloy Ghosh: Innovator in Antibody Therapeutics
Introduction
Maloy Ghosh is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of biotechnology, particularly in the development of novel antibodies for therapeutic applications. With a total of 9 patents to his name, Ghosh is recognized for his innovative approaches to addressing complex medical challenges.
Latest Patents
Ghosh's latest patents focus on antibodies that bind to C-type lectin domain family 2 member D (CLEC2D). The present disclosures relate to novel anti-CLEC2D antibodies and their related compositions and methods of use. These antibodies are utilized as therapeutics and have applications in prognostic and diagnostic settings for various cancers and other diseases. His work in this area highlights the potential of these antibodies to improve patient outcomes through targeted therapies.
Career Highlights
Throughout his career, Maloy Ghosh has been dedicated to advancing the field of antibody therapeutics. His innovative research has led to the development of groundbreaking solutions that address critical health issues. Ghosh's expertise and commitment to scientific advancement have positioned him as a key figure in the biotechnology sector.
Collaborations
Ghosh has collaborated with notable professionals in his field, including Kavitha Iyer Rodrigues and Sunit Maity. These collaborations have fostered a dynamic environment for innovation and have contributed to the success of his research initiatives.
Conclusion
Maloy Ghosh's contributions to the field of biotechnology, particularly in the development of anti-CLEC2D antibodies, underscore his role as a leading inventor. His work not only advances scientific knowledge but also holds promise for improving therapeutic strategies in cancer treatment and beyond.